Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Array BioPharma Inc.
DescriptionSelective neurotrophic tyrosine kinase (TRK) inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerLoxo Oncology Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today